Oxolife is a biotechnology company in the clinical phase of development.
OXOlife has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in February 2026.
OXOlife's investors include Inveready, EIC Accelerator, Centre for the Development of Industrial Technology (CDTI), BStartup - Banc Sabadell, EIT Health.
OXOlife is headquartered in San Quírico Safaja, Spain.
Oxolife is a biotechnology company in the clinical phase of development.
OXOlife is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OXOlife — Funding & Investors." VCBacked, February 22, 2026, https://www.vcbacked.co/company/oxolife. Accessed August 14, 2026.
VCBacked. (2026). OXOlife — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/oxolife
{{cite web |title=OXOlife — Funding & Investors |url=https://www.vcbacked.co/company/oxolife |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated